Trial intelligence / Profile preview

Nebulized Albuterol for CHF Exacerbation

NCT01375361Phase 3Withdrawn

Sponsor
University of California, San Francisco
Start
Apr 2009
Primary completion
Jul 2010
Countries
1
01

Overview

A Phase 3 trial of albuterol dry powder inhaler in heart failure (HF), sponsored by University of California, San Francisco. Planned start Apr 2009; status: withdrawn.

02

Drugs

albuterol dry powder inhaler
03

Conditions

heart failure (HF)

Beyond the preview

Go deeper on NCT01375361.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01375361.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call